M. Yokoyama

Efficacy and safety of levodopa–carbidopa intestinal gel from a study in Japanese, Taiwanese, and Korean advanced Parkinson’s disease patients

C. Tsai, M. Mihara, B. Jeon, 2016, npj Parkinson's Disease.

A post hoc comparison of levodopa-carbidopa intestinal gel daytime monotherapy vs polytherapy safety and efficacy in patients with advanced Parkinson's disease: Results from 6 phase 3/3b open-label studies

C. Zadikoff, W. Robieson, J. Benesh, 2019, Clinical parkinsonism & related disorders.

Safety and efficacy of levodopa-carbidopa intestinal gel: results from an open-label extension study in Japanese, Korean and Taiwanese patients with advanced Parkinson’s disease

C. Tsai, M. Mihara, M. Facheris, 2018, Therapeutic advances in neurological disorders.

Efficacy and safety of upadacitinib over 84 weeks in Japanese patients with rheumatoid arthritis (SELECT-SUNRISE)

M. Kawano, Yoshiya Tanaka, T. Takeuchi, 2021, Arthritis Research & Therapy.

Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results

Hidetoshi Takahashi, S. Imafuku, A. Morita, 2020, The Journal of dermatology.

Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa

Hidetoshi Takahashi, S. Imafuku, A. Morita, 2019, The Journal of dermatology.